Rheumatoid arthritis

Serial ACPA measures unnecessary in seronegative RA patients

Repeat testing for autoantibodies that signal more severe disease in rheumatoid arthritis patients that are seronegative for the biomarkers after treat to target therapy is started is neither helpful or cost effective, say Australian rheumatologists. That’s because patients who are double negative for rheumatoid factor (RF) and anti-citrullinated peptide antibody (ACPA) are highly unlikely to ...

Already a member?

Login to keep reading.

© 2021 the limbic